Cuende N, Herrera C, Keating A. When the best is the enemy of the good: the case of bone-marrow mononuclear cells to treat ischemic syndromes. Haematologica [Internet]. 2013Feb.28 [cited 2026Nov.14];98(3):323-4. Available from: https://haematologica.org/article/view/6577